Relitil 25mg/ml Injection

Relitil 25mg/ml Injection belongs to a group of medications called 'antipsychotics and antiemetics indicated for the symptomatic management of psychotic disorders such as schizophrenia. It is also used to treat tetanus, acute intermittent porphyria, intractable hiccups, and severe behavioural problems in children, as well as to prevent nausea and vomiting and to relieve restlessness and apprehension prior to surgery.

Relitil 25mg/ml Injection contains 'Chlorpromazine', which works by blocking the action of a chemical messenger called dopamine that affects mood and thoughts.

In some cases, Relitil 25mg/ml Injection may cause side effects such as dry mouth, constipation, weight gain, and pain at the site of injection. Most of these side effects of Relitil 25mg/ml Injection do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.

Inform your doctor if you are pregnant or breastfeeding before receiving Relitil 25mg/ml Injection; your doctor will prescribe only if the benefits outweigh the risks. The safety and effectiveness of Relitil 25mg/ml Injection in children below 12 months have not been established. Avoid driving or operating heavy machinery as Relitil 25mg/ml Injection may impair mental and/or physical ability. Keep your doctor informed about your health condition and medications to rule out any interactions/side effects.

Relitil 25mg/ml Injection belongs to a group of medications called 'antipsychotics and antiemetics indicated for the symptomatic management of psychotic disorders such as schizophrenia. It is also used to treat tetanus, acute intermittent porphyria, intractable hiccups, and severe behavioural problems in children, as well as to prevent nausea and vomiting and to relieve restlessness and apprehension prior to surgery. Relitil 25mg/ml Injection may also be used to control the manifestations of the manic phase of bipolar disorder in the short-term treatment of hyperactive children, childhood schizophrenia and autism. Relitil 25mg/ml Injection works by blocking the action of a chemical messenger called dopamine that affects mood and thoughts.

Do not take Relitil 25mg/ml Injection if you are allergic to any of the components if you have circulatory collapse, CNS depression, or bone marrow depression. Inform your doctor if you have epilepsy, Parkinson's disease, hypoparathyroidism, myasthenia gravis, prostate hypertrophy, retinopathy, respiratory disease, Reye's syndrome, glaucoma, high/low blood pressure, asthma, heart, kidney or liver problems. Consult your doctor if you are pregnant or breastfeeding; your doctor will prescribe only if the benefits outweigh the risks. Relitil 25mg/ml Injection may cause tardive dyskinesia (movement disorder), neuroleptic malignant syndrome (a rare reaction associated with the use of antipsychotic drugs), postural hypotension, and motor and sensory instability; talk to your doctor if you have any concerns.

• Relitil 25mg/ml Injection may cause false positive phenylketonuria (PKU) test results. Inform the person doing the tests that you are taking Relitil 25mg/ml Injection.
• Relitil 25mg/ml Injection may cause high blood sugar or intolerance to glucose. Regular monitoring of blood glucose levels whilst on treatment with Relitil 25mg/ml Injection is advised.